Movement Alert｜JOINN Falls 5.34% in Regular Trading, Sector Weakness Compounds Ongoing Core Business Profitability Concerns

Market Focus07-30

On July 30, JOINN fell 5.34% in regular trading, trading at HK$22.28/share, with turnover of HK$47.99 million.

The decline was driven by broad weakness across the Life Sciences Tools & Services sector, with WUXI BIO down 4.37%, INSILICO down 3.72%, WUXI APPTEC down 3.22%, and GENSCRIPT BIO down 2.87%, reflecting widespread selling pressure across the industry.

Market concerns over the company's earnings quality continued to weigh on sentiment. The company's first-half profit surge was primarily attributable to approximately RMB 703 million to 777 million in fair value changes from experimental monkey biological assets, while core laboratory service operations posted net profit of only negative RMB 142 million to RMB 64.97 million, indicating that the main business has yet to achieve meaningful profitability recovery. Additionally, profit-taking pressure persisted following significant prior price volatility, with the stock having experienced a limit-up session on July 27 followed by an 8.31% decline on July 28.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151467059?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 11:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151467059","market":"us","top_or_hot":-1,"title":"Movement Alert｜JOINN Falls 5.34% in Regular Trading, Sector Weakness Compounds Ongoing Core Business Profitability Concerns","media":"Market Focus","content":"<p><p>On July 30, JOINN fell 5.34% in regular trading, trading at HK$22.28/share, with turnover of HK$47.99 million.</p><p>The decline was driven by broad weakness across the Life Sciences Tools & Services sector, with WUXI BIO down 4.37%, INSILICO down 3.72%, WUXI APPTEC down 3.22%, and GENSCRIPT BIO down 2.87%, reflecting widespread selling pressure across the industry.</p><p>Market concerns over the company's earnings quality continued to weigh on sentiment. The company's first-half profit surge was primarily attributable to approximately RMB 703 million to 777 million in fair value changes from experimental monkey biological assets, while core laboratory service operations posted net profit of only negative RMB 142 million to RMB 64.97 million, indicating that the main business has yet to achieve meaningful profitability recovery. Additionally, profit-taking pressure persisted following significant prior price volatility, with the stock having experienced a limit-up session on July 27 followed by an 8.31% decline on July 28.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JOINN Falls 5.34% in Regular Trading, Sector Weakness Compounds Ongoing Core Business Profitability Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JOINN Falls 5.34% in Regular Trading, Sector Weakness Compounds Ongoing Core Business Profitability Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-30 11:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 30, JOINN fell 5.34% in regular trading, trading at HK$22.28/share, with turnover of HK$47.99 million.</p><p>The decline was driven by broad weakness across the Life Sciences Tools & Services sector, with WUXI BIO down 4.37%, INSILICO down 3.72%, WUXI APPTEC down 3.22%, and GENSCRIPT BIO down 2.87%, reflecting widespread selling pressure across the industry.</p><p>Market concerns over the company's earnings quality continued to weigh on sentiment. The company's first-half profit surge was primarily attributable to approximately RMB 703 million to 777 million in fair value changes from experimental monkey biological assets, while core laboratory service operations posted net profit of only negative RMB 142 million to RMB 64.97 million, indicating that the main business has yet to achieve meaningful profitability recovery. Additionally, profit-taking pressure persisted following significant prior price volatility, with the stock having experienced a limit-up session on July 27 followed by an 8.31% decline on July 28.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"","article_id":"1151467059","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151467059","pubTimestamp":1785380587,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 30, JOINN fell 5.34% in regular trading, trading at HK$22.28/share, with turnover of HK$47.99 million.The decline was driven by broad weakness across the Life Sciences Tools & Services...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06127":"昭衍新药"},"translate_title":"走势警报|JOINN 常规交易中下跌 5.34%，行业疲软加剧了对核心业务盈利能力的持续担忧","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"On July 30, JOINN fell 5.34% in regular trading, trading at HK$22.28/share, with turnover of HK$47.99 million.The decline was driven by broad weakness across the Life Sciences Tools & Services sector, with WUXI BIO down 4.37%, INSILICO down 3.72%, WUXI APPTEC down 3.22%, and GENSCRIPT BIO down 2.87%, reflecting widespread selling pressure across the industry.Market concerns over the company's earnings quality continued to weigh on sentiment. The company's first-half profit surge was primarily attributable to approximately RMB 703 million to 777 million in fair value changes from experimental monkey biological assets, while core laboratory service operations posted net profit of only negative RMB 142 million to RMB 64.97 million, indicating that the main business has yet to achieve meaningful profitability recovery. Additionally, profit-taking pressure persisted following significant prior price volatility, with the stock having experienced a limit-up session on July 27 followed by an 8.31% decline on July 28.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151467059","isCrawlerRequest":true}